Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instituto Mario Penna provides comprehensive oncology care to patients across Minas Gerais state in Brazil. It serves approximately 70% of new cancer cases in Belo Horizonte and its metropolitan region and over one-fifth of all new cases statewide. The institute integrates advanced technologies like next-generation sequencing for blood cancers through partnerships with companies such as SOPHiA GENETICS. Its Teaching and Research Center collaborates with academic institutions on translational research projects focused on improving diagnosis and treatment outcomes for various tumor types[4][5][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instituto Mario Penna.